FGFR3 and neoplasm: The incidence of FGFR3 alterations or mutations vary, depending on tumor stage, and occur in up to 80% of stage Ta tumors and are associated with favorable outcomes In stage T2 and greater tumors, FGFR3 mutations are less common (10–20%) [36].